5.42
price up icon2.07%   +0.11
 
loading

ProPhase Labs Inc Stock (PRPH) Forecast

The ProPhase Labs Inc (PRPH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.7967, representing a -11.50% decrease from the current price of $5.42. The highest analyst price target is $5.2952, and the lowest is $4.2982.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PRPH Price Target
Average 4.611 (-14.93% Downside)
loading

Is ProPhase Labs Inc (PRPH) A Buy Now?

Oscillators
Name Value Action
RSI(14) 49.08 Neutral
STOCH(9,6) 43.91 Neutral
STOCHRSI(14) 38.66 Neutral
MACD(12,26) -0.2221 Sell
ADX(14) 16.53 Neutral
William %R -67.99 Neutral
CCI(14) 6.6925 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
4.992
Buy
5.2069
Buy
MA20
5.6117
Sell
5.4177
Buy
MA50
5.5089
Sell
5.4743
Sell
MA100
5.1903
Buy
5.3579
Buy
MA200
5.1199
Buy
5.6928
Sell
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, PRPH could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on PRPH, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 49.08 indicates that PRPH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 43.91 indicates that PRPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.66 indicates that PRPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 16.53 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 6.6925 indicates that PRPH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term PRPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about ProPhase Labs Inc financial reports and earnings history, ProPhase Labs Inc (PRPH) stock could reach $7.518 by 2030, $20.28 by 2040 and $24.09 by 2050. See the projected annual prices until 2050 of the ProPhase Labs Inc stock below:

  • ProPhase Labs Inc (PRPH) is expected to reach an average price of $12.26 in 2035, with a high prediction of $12.98 and a low estimate of $11.52. This indicates an $126.17% rise from the last recorded price of $5.42.
  • ProPhase Labs Inc (PRPH) stock is projected to chart a bullish course in 2040, with an average price target of $19.06, representing an $251.67% surge from its current level. The forecast ranges from a conservative $17.85 to a sky-high $20.28.
  • Our analysts predict ProPhase Labs Inc (PRPH) to jump 365.29% by 2045, soaring from $22.00 to an average price of $25.22, potentially reaching $25.51. While $22.00 is the low estimate, the potential upside is significant.
  • ProPhase Labs Inc (PRPH) stock is expected to climb by 2050, reaching an average of $23.90, a $340.92% jump from its current level. However, a wide range of estimates exists, with high and low targets of $24.09 and $22.27, respectively, highlighting the market's uncertainty.

ProPhase Labs Inc Stock (PRPH) Year by Year Forecast

ProPhase Labs Inc Stock (PRPH) Price Forecast for 2024

Our forecast for PRPH stock price in 2024 now indicates an average price target of $5.7034 with a high forecast of $7.48 and a low forecast of $3.9268. The average prediction reflects an increase of +5.23% from the last recorded price of $5.42.
Month Average Low High Change from today's price
June, 2024 $4.4482 $4.2982 $5.2952 -17.93%
July, 2024 $4.3155 $4.2466 $4.4948 -20.38%
August, 2024 $4.3173 $4.1573 $4.3318 -20.34%
September, 2024 $4.0746 $3.9268 $4.3382 -24.82%
October, 2024 $4.2264 $4.0746 $4.3046 -22.02%
November, 2024 $4.1782 $3.9573 $4.3882 -22.91%
December, 2024 $4.5101 $4.30 $4.6701 -16.79%

ProPhase Labs Inc Stock (PRPH) Price Forecast for 2025

ProPhase Labs Inc Stock (PRPH) is expected to reach an average price of $8.8606 in 2025, with a high prediction of $13.83 and a low estimate of $3.8928. This indicates an +63.48% rise from the last recorded price of $5.42.
Month Average Low High Change from today's price
January, 2025 $4.2073 $4.1767 $4.5255 -22.37%
February, 2025 $4.2192 $4.1883 $4.5231 -22.16%
March, 2025 $4.361 $4.1755 $4.541 -19.54%
April, 2025 $4.2683 $4.1374 $4.5464 -21.25%
May, 2025 $4.1851 $4.1201 $5.0692 -22.78%
June, 2025 $4.1319 $4.101 $4.2365 -23.77%
July, 2025 $3.9292 $3.8928 $5.0137 -27.51%
August, 2025 $4.071 $3.9347 $4.191 -24.89%
September, 2025 $5.2179 $4.0765 $7.1129 -3.73%
October, 2025 $5.8501 $4.9283 $5.9501 +7.94%
November, 2025 $7.782 $5.5056 $7.832 +43.58%
December, 2025 $12.15 $7.0829 $13.83 +124.16%

ProPhase Labs Inc Stock (PRPH) Price Forecast for 2026

The predicted value for ProPhase Labs Inc (PRPH) in 2026 is set at an average of $12.99. Estimates vary from a peak of $18.76 to a trough of $7.2111, indicating an +139.58% surge from the present price of $5.42.
Month Average Low High Change from today's price
January, 2026 $13.01 $9.8856 $13.52 +140.06%
February, 2026 $13.27 $11.13 $14.52 +144.89%
March, 2026 $14.93 $11.51 $18.76 +175.55%
April, 2026 $10.41 $10.02 $15.12 +92.10%
May, 2026 $9.2738 $8.6375 $11.25 +71.10%
June, 2026 $8.1657 $7.8257 $10.66 +50.66%
July, 2026 $9.1929 $7.2111 $9.3229 +69.61%
August, 2026 $8.5048 $7.2684 $9.8293 +56.91%
September, 2026 $8.802 $8.2302 $10.81 +62.40%
October, 2026 $9.3539 $8.3939 $10.94 +72.58%
November, 2026 $8.1757 $8.0193 $9.1593 +50.84%
December, 2026 $8.023 $7.6866 $8.7113 +48.03%

ProPhase Labs Inc Stock (PRPH) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for ProPhase Labs Inc (PRPH) is $13.22, with a high forecast of $18.45 and a low forecast of $7.9985. This indicates an +143.98% increase from the last price of $5.42.
Month Average Low High Change from today's price
January, 2027 $8.9348 $7.9985 $9.0648 +64.85%
February, 2027 $9.2766 $8.5151 $9.57 +71.16%
March, 2027 $10.83 $8.9975 $11.09 +99.89%
April, 2027 $10.08 $9.6557 $11.02 +85.90%
May, 2027 $10.14 $9.5812 $10.29 +87.04%
June, 2027 $9.7348 $9.2794 $10.11 +79.61%
July, 2027 $10.42 $9.5203 $10.90 +92.19%
August, 2027 $10.55 $10.10 $11.70 +94.62%
September, 2027 $12.21 $9.4494 $12.59 +125.20%
October, 2027 $14.91 $11.79 $14.93 +175.05%
November, 2027 $17.18 $14.65 $18.45 +216.96%
December, 2027 $15.01 $11.89 $18.19 +176.88%

ProPhase Labs Inc Stock (PRPH) Price Forecast for 2028

In 2028, ProPhase Labs Inc (PRPH) is projected to reach an average price of $13.07, with a high projection of $16.13 and a low estimate of $10.01. This indicates an +141.14% rise from the last price of $5.42.
Month Average Low High Change from today's price
January, 2028 $14.37 $13.93 $16.13 +165.10%
February, 2028 $15.28 $13.17 $15.57 +181.93%
March, 2028 $15.30 $12.15 $15.65 +182.24%
April, 2028 $13.69 $13.21 $15.99 +152.57%
May, 2028 $12.98 $11.85 $14.20 +139.42%
June, 2028 $11.45 $11.23 $13.23 +111.23%
July, 2028 $11.25 $10.89 $11.84 +107.57%
August, 2028 $11.15 $10.01 $11.57 +105.68%
September, 2028 $11.60 $10.69 $12.31 +114.01%
October, 2028 $11.39 $10.95 $13.36 +110.17%
November, 2028 $11.45 $11.25 $13.42 +111.32%
December, 2028 $10.90 $10.46 $11.34 +101.11%

ProPhase Labs Inc Stock (PRPH) Price Forecast for 2029

The 2029 price forecast for ProPhase Labs Inc Stock (PRPH) is $9.2384 on average, with a high prediction of $11.25 and a low estimate of $7.23. This represents an +70.45% increase from the previous price of $5.42.
Month Average Low High Change from today's price
January, 2029 $10.71 $10.32 $11.09 +97.56%
February, 2029 $7.8395 $7.6095 $10.89 +44.64%
March, 2029 $7.9314 $7.6904 $8.6259 +46.34%
April, 2029 $8.1532 $7.8968 $8.2932 +50.43%
May, 2029 $8.0505 $7.9005 $8.7649 +48.53%
June, 2029 $8.6823 $7.8859 $9.3414 +60.19%
July, 2029 $8.4241 $8.0037 $8.8241 +55.43%
August, 2029 $8.7814 $8.2059 $8.9796 +62.02%
September, 2029 $8.1932 $8.1932 $8.9678 +51.17%
October, 2029 $10.22 $8.1021 $10.46 +88.57%
November, 2029 $8.4823 $8.3732 $11.25 +56.50%
December, 2029 $7.3909 $7.23 $9.1032 +36.36%

ProPhase Labs Inc Stock (PRPH) Price Forecast for 2030

ProPhase Labs Inc Stock (PRPH) is expected to reach an average price of $6.8872 in 2030, with a high forecast of $7.5484 and a low forecast of $6.226. This signifies an +27.07% surge from the last price of $5.42.
Month Average Low High Change from today's price
January, 2030 $7.372 $7.2018 $7.518 +36.01%
February, 2030 $6.5891 $6.4802 $7.4564 +21.57%
March, 2030 $6.5612 $6.54 $6.5928 +21.05%
April, 2030 $6.4289 $6.2964 $6.6264 +18.61%
May, 2030 $6.551 $6.226 $6.6092 +20.87%
June, 2030 $6.5466 $6.2946 $6.5587 +20.79%
July, 2030 $6.8092 $6.3757 $6.9792 +25.63%
August, 2030 $6.7529 $6.7201 $7.0401 +24.59%
September, 2030 $6.6665 $6.5741 $6.9114 +23.00%
October, 2030 $6.8135 $6.6032 $6.9368 +25.71%
November, 2030 $6.6902 $6.5947 $6.9938 +23.44%
December, 2030 $6.7584 $6.7084 $7.5484 +24.69%
diagnostics_research LH
$201.32
price up icon 0.53%
$117.93
price down icon 4.89%
diagnostics_research WAT
$321.25
price up icon 1.80%
$309.02
price up icon 2.64%
diagnostics_research MTD
$1,251.95
price up icon 0.17%
$480.60
price up icon 1.00%
Cap:     |  Volume (24h):